Dr. Vincent has over thirty-seven (37) years of experience in the healthcare industry, with specialized expertise in the biotechnology and pharmaceutical sectors. For more than thirty (30) years, he has focused extensively on Commissioning, Qualification, and Validation (CQV), leading complex facility start-ups, regulatory readiness initiatives, and lifecycle validation programs. He holds a Bachelor of Science (B.Sc.) in Industrial Microbiology, a Master of Public Health (M.P.H.), and a Doctor of Public Health (DrPH).

Brings extensive hands-on experience across multiple domains of Regulatory Affairs, having worked directly with regulatory agencies to address FDA Form 483 observations, Warning Letters, and Consent Decree remediation initiatives. Demonstrated expertise spans Quality Assurance, Commissioning and Qualification (C&Q), and Engineering support, including the preparation of regulatory submissions. Also have a cleanroom design review and the setup and qualification of microbiology laboratories, ensuring compliance with global regulatory expectations and current industry best practices.

He is strong in Upstream and Downstream Process Development and Validation, as well as in developing and implementing Cleaning Development and Validation, Aseptic Process, and Environmental Monitoring Programs. Most of his career has been in the biological vaccine industry, but he has also supported the Medical Device, Biopharmaceutical, Pharmaceutical, Nutraceutical, and biological industries.

He is actively engaged in multiple technical committees focused on developing industry-relevant software platforms that integrate artificial intelligence capabilities for predictive pandemic modeling. In parallel, he contributes to strategic initiatives to implement commissioning-ready software programs aligned with construction documentation, design specifications, and digital project delivery frameworks. This work integrates user requirements, engineering documentation, and lifecycle validation deliverables to ensure regulatory compliance, operational readiness, and improved validation efficiency, ultimately streamlining the CQV process and optimizing overall project cost and schedule performance.

Dr Vincent is an ASTM committee member for Manufacture of Pharmaceutical and Biopharmaceutical Products – E55 (20-07), Microbial/Sterility Assurance for Pharmaceutical and Biopharmaceutical Products – E55.06 (20-01), WK74412 – New Standard Critical Airflow Visualization and WK69826 – Standard Template for Environmental Monitoring Trend Analysis, Best Practices for Microbial Control of ATMP, and Cleaning Quality by Design, and Risk-Based Cleaning. He also co-authored the ISPE GUIDE: Cleaning Validation Lifecycle – Applications, Methods & Controls.

He taught at San Diego State University (SDSU) in the Master’s in Regulatory Affairs program, Field RA-776: Validation Technology.

Inducted into the Delta Omega Honorary Society in Public Health, which was founded in 1924 at Johns Hopkins University within the School of Hygiene and Public Health, to promote the graduate study of public health, and to recognize outstanding achievement in the new field.